Investments and innovations lead to best results in the company’s more than 170-year history
- Double-digit revenue growth to EUR 5.348 billion
- EBIT increases to EUR 770 million
- Positive contribution from all segments
- Growth with leading-edge EUV technology
- ZEISS continues to focus on innovation, global investments and expansion
OBERKOCHEN/Germany, STUTTGART/Germany, 2017-12-13.
In the past 2016/17 fiscal year (ended 30 September 2017), ZEISS increased both its revenue and earnings to a record level: revenue rose by 10 percent to EUR 5.348 billion (prior year: EUR 4.881 billion). At EUR 770 million, earnings before interest and tax (EBIT) were significantly above the already high level of the previous year (615 million). The EBIT margin has increased to over 14 percent. Order intake grew by a healthy 12 percent and is now at EUR 5.625 billion, underscoring the growth ambitions of the technology company.
“All four segments – Research & Quality Technology, Medical Technology, Vision Care/Consumer Products and Semiconductor Manufacturing Technology – are either at or above their target returns and have made a positive contribution to the most successful fiscal year in the history of ZEISS,” said Prof. Dr. Michael Kaschke, President & CEO of Carl Zeiss AG, at the annual press conference in Stuttgart. “This development was not and is not just a matter of course. Rather, it is the result of the tremendous efforts made by all employees and partners over a long period of time. The consistent implementation of the strategic Agenda has now made a real impact and significantly increased competitiveness. Thanks to investments in cutting-edge Innovation and Customer Centers, global partnerships and strategic expansions, we have focused entirely on the needs of our customers,” said Kaschke, explaining the company’s strategy.
|Revenue in € million|
|Research & Quality Technology||1,538||1,466||+5%|
|Vision Care/Consumer Products||1,108||1,089||+2%|
|Semiconductor Manufacturing Technology||1,212||972||+25%|